Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

June 2027 167

  1. Study completion Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931535

  2. Primary completion Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931535

  3. Primary completion Efficacy and Safety Study of Isuzinaxib in Subjects With DKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06962098

  4. Study completion Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989723

  5. Study completion Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07007676

  6. Primary completion Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07011147

  7. Primary completion Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07021313

  8. Primary completion Early Screening and Treatment of Heart Complication in Sickle Cell Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023666

  9. Study completion Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07040085

  10. Primary completion Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07040085

  11. Study completion Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07047014

  12. Primary completion Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07048808

  13. Study completion PRIMARY Ancillary Substudy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07103733

  14. Primary completion PRIMARY Ancillary Substudy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07103733

  15. Study completion Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07118449

  16. Primary completion Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173712

  17. Study completion Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220759

  18. Primary completion Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241520

  19. Primary completion Effect of Empagliflozin on Inflammation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07292909

  20. Study completion Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07300358

  21. Primary completion Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07300358

  22. Primary completion Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07307235

  23. Study completion Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07336329

  24. Study completion CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07351643

  25. Primary completion CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07351643

  26. Primary completion Efficacy and Safety of Micra AV2 Transcatheter Pacing System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07356505

  27. Primary completion Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07362446

  28. Primary completion DNV001 Injection in Patients With Hypercholesterolemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07391722

  29. Primary completion ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07484009

  30. Study completion Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613840

  31. Study completion Prediction of Atrial Fibrillation Using Polygenic Risk Score Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07641582

  32. Primary completion A Study of Probiotics in Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07651332

  33. Study completion A Randomized Trial of Carotid Artery Stenting With Balloon Guide Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678164

  34. Primary completion Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07707076

  35. Primary completion LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07773051

  36. Study completion Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07792239

  37. Primary completion Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07792239

  38. Primary completion Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796217

July 2027 107

  1. Study completion Continuous Glucose Monitor Use in Pregnancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05317585

  2. Primary completion Cholesterol Lowering and Residual Risk in Diabetes, Type 1 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05641753

  3. Primary completion A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05913622

  4. Study completion Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06174220

  5. Study completion Wearable Evaluation of Ambulatory Readings for Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06610448

  6. Primary completion Wearable Evaluation of Ambulatory Readings for Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06610448

  7. Primary completion Evaluation of Balloon Guide Catheter as Proximal Protection During Carotid Artery Stenting (EMBO-PROTECT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07576790

  8. Study completion Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617376

  9. Study start RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696975

  10. Primary completion Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07706075

  11. Primary completion A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07872436

  12. Study completion High Resolution, High-speed Multimodal Ophthalmic Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04129021

  13. Primary completion High Resolution, High-speed Multimodal Ophthalmic Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04129021

  14. Study completion LIFE-BTK Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04227899

  15. Primary completion Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05102019

  16. Primary completion ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172960

  17. Study completion Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05199194

  18. Study completion Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05199662

  19. Study completion The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05374291

  20. Primary completion The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05374291

  21. Primary completion RESPONDER-HF Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05425459

  22. Primary completion Dutch Intracerebral Hemorrhage Surgery Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05460793

  23. Study completion CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05508256

  24. Primary completion Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05821426

  25. Study completion Assessment of Combined CCM and ICD Device in HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05855135

  26. Primary completion ASCVD Management Using CCTA in Prostate Cancer Patients on ADT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05879913

  27. Study completion Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910125

  28. Primary completion Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910125

  29. Primary completion Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05983757

  30. Primary completion AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029660

  31. Study completion Efficacy and Safety of Lactoferrin in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06427200

  32. Primary completion Efficacy and Safety of Lactoferrin in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06427200

  33. Study completion International Care Bundle Evaluation in Cerebral Hemorrhage Research Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06429332

  34. Study completion Closed-loop in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06579404

  35. Study completion ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06611319

  36. Study completion Protocol for Improvement of Therapy With Warfarin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06789588

  37. Study completion Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06866236

  38. Primary completion Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07017270

  39. Study completion Semaglutide for Smoking Cessation in Patients With Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059377

  40. Primary completion The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07143019

  41. Study completion Effect of Add-on L-Arginine Therapy on Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394270

  42. Study completion A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07438444

  43. Primary completion A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07438444

  44. Study completion Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537088

  45. Study start Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07577739

  46. Study completion PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07711821

  47. Primary completion PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07711821

  48. Study completion The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739160

  49. Primary completion Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752940

  50. Study completion A Study of HRS-4729 Injection in Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843862

  51. Primary completion Vortosiran for VTE Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07850453

  52. Study completion MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874269

  53. Primary completion MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874269

  54. Study completion Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06538974

  55. Primary completion Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06538974

  56. Primary completion IVUS Guided PCI in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06813534

  57. Study completion A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647003

  58. Primary completion Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06470022

  59. Primary completion SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06590012

  60. Study completion REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07213778

  61. Study completion Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04040959

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy Registry record

    Expected 2019-06-15; that period ended on 2019-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03983187

  2. Primary completion GutHeart: Targeting Gut Microbiota to Treat Heart Failure Registry record

    Expected 2019-06-20; that period ended on 2019-06-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02637167

  3. Study start Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes Registry record

    Expected 2019-06-20; that period ended on 2019-06-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03421119

  4. Study completion The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01774058

  5. Primary completion The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01774058

  6. Study completion Comparative Effectiveness of the Minimally Invasive Coronary Artery Bypass Grafting Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02047266

  7. Study completion Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02502110

  8. Study completion Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI) Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02512978

  9. Primary completion PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02541032

  10. Study completion ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial) Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02609698

  11. Primary completion Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02722447

  12. Primary completion Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02859480

  13. Study completion Effect of External Counter Pulsation on Coronary Artery Disease Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075124

  14. Study completion Effect of External Counter Pulsation on Ischemic Stroke Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075137

  15. Study completion Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03159052

  16. Study completion Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252665

  17. Primary completion Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252665

  18. Study completion CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03444857

  19. Study completion H-Type Hypertension Precision Medicine Trial Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03472508

  20. Primary completion BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations Registry record

    Expected 2019-06; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03548272

  21. Primary completion Primary Technology Enhanced Care in Hypertension Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03698890

  22. Study completion Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2 Registry record

    Expected 2019-06-30; that period ended on 2019-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03815305

  23. Study completion Tecarfarin Anti-Coagulation Trial (TACT) Registry record

    Expected 2019-07-01; that period ended on 2019-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02522221

  24. Study start Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction Registry record

    Expected 2019-07-01; that period ended on 2019-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753269

  25. Study start A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. Registry record

    Expected 2019-07-20; that period ended on 2019-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04028518

  26. Primary completion Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) Registry record

    Expected 2019-07-30; that period ended on 2019-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03664414

  27. Primary completion Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence Registry record

    Expected 2019-07-30; that period ended on 2019-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753568

  28. Study completion Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01475799

  29. Study completion Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02425371

  30. Study completion Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02660866

  31. Primary completion Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02660866

  32. Primary completion Consolidating Tools for Outcomes in Resuscitation Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02676024

  33. Primary completion Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02738749

  34. Study completion Integrative Care for Type 2 Diabetes Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02843724

  35. Study start Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter Registry record

    Expected 2019-07; that period ended on 2019-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03987321

  36. Primary completion Magneto-rheology to Lower Blood Pressure Registry record

    Expected 2019-08-09; that period ended on 2019-08-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03783117

  37. Study start LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2019-08-30; that period ended on 2019-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04060914

  38. Study completion Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria Registry record

    Expected 2019-08; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01500590

  39. Study completion Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease Registry record

    Expected 2019-08-31; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01932203

  40. Study completion Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. Registry record

    Expected 2019-08; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02919059

  41. Study completion Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population Registry record

    Expected 2019-08-31; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03696940

  42. Study completion Magneto-rheology to Lower Blood Pressure Registry record

    Expected 2019-08-31; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03783117

  43. Study start Efficacy and Safety of Sotalol in Children With Arrhythmia Registry record

    Expected 2019-08; that period ended on 2019-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03895411

  44. Primary completion Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients Registry record

    Expected 2019-09-01; that period ended on 2019-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271879

  45. Primary completion Heart Monitoring Device After Acute Myocardium Infarction Registry record

    Expected 2019-09-01; that period ended on 2019-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03494751

  46. Study completion Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence Registry record

    Expected 2019-09-01; that period ended on 2019-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753568

  47. Study start Chinese Medicine Treat for Hypertensive Renal Injury Registry record

    Expected 2019-09-10; that period ended on 2019-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04078711

  48. Study start Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. Registry record

    Expected 2019-09-15; that period ended on 2019-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03721614

  49. Study completion Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST) Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01930773

  50. Study completion Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02162550

  51. Study completion Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS) Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02534545

  52. Primary completion Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS) Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02534545

  53. Primary completion A RCT on Supraglottic Airway Versus Endotracheal Intubation in OHCA Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02967952

  54. Study completion Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03274089

  55. Primary completion Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03274089

  56. Study completion An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03279263

  57. Primary completion An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03279263

  58. Primary completion China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03532620

  59. Primary completion Fixed-Free HTN Trial Registry record

    Expected 2019-09-30; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03578042

  60. Primary completion Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03666806

  61. Primary completion Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis Registry record

    Expected 2019-09; that period ended on 2019-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04034966

  62. Study start DUAL Antithrombotic Therapy in Patients With AF and ACS Registry record

    Expected 2019-10-01; that period ended on 2019-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04023630

  63. Study start Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus Registry record

    Expected 2019-10-01; that period ended on 2019-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04120623

  64. Study start Cardiac Ganglionated Plexus Ablation Before Permanent Pacemaker Implantation in Patients With Sick Sinus Syndrome Registry record

    Expected 2019-10-28; that period ended on 2019-10-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04149886

  65. Study completion Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02049229

  66. Study completion Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants. Registry record

    Expected 2019-10-31; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02056223

  67. Primary completion Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants. Registry record

    Expected 2019-10-31; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02056223

  68. Study completion Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02422888

  69. Primary completion Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02948998

  70. Primary completion Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina. Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03171597

  71. Primary completion Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina. Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179514

  72. Primary completion Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina. Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179527

  73. Primary completion Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina. Registry record

    Expected 2019-10; that period ended on 2019-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179618

  74. Primary completion Trial of Oral Melatonin in Elevated Blood Pressure Registry record

    Expected 2019-11-01; that period ended on 2019-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764020

  75. Study start One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease Registry record

    Expected 2019-11-01; that period ended on 2019-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04148820

  76. Study completion Functional Training for the Prevention of Deep Venous Thrombosis Registry record

    Expected 2019-11-10; that period ended on 2019-11-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03740633

  77. Primary completion Functional Training for the Prevention of Deep Venous Thrombosis Registry record

    Expected 2019-11-10; that period ended on 2019-11-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03740633

  78. Primary completion Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting Registry record

    Expected 2019-11-15; that period ended on 2019-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03195673

  79. Primary completion Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy Registry record

    Expected 2019-11-15; that period ended on 2019-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03983187

  80. Primary completion Effect of CPAP in the Worsening of Renal Function in Early Stages of Chronic Kidney Disease (CKD) Registry record

    Expected 2019-11-20; that period ended on 2019-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03319888

  81. Primary completion Stitch Closure of PFO and Septal Repair Registry record

    Expected 2019-11-20; that period ended on 2019-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03373929

  82. Study start Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Registry record

    Expected 2019-11-20; that period ended on 2019-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04161001

  83. Primary completion Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients Registry record

    Expected 2019-11-25; that period ended on 2019-11-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03754738

  84. Primary completion Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02592980

  85. Study completion The Use Of FFR Guided PCI Versus Complete Revascularization and Treatment Of Infarct Related Artery Only In Patients With STEMI Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02637440

  86. Primary completion The Use Of FFR Guided PCI Versus Complete Revascularization and Treatment Of Infarct Related Artery Only In Patients With STEMI Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02637440

  87. Primary completion Hospital-based Diabetes Prevention Study in Korea Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02981121

  88. Study completion TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI Registry record

    Expected 2019-11-30; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03145194

  89. Primary completion Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03342807

  90. Study completion Optimizing Patient Usability Experience for Chronic Care Registry record

    Expected 2019-11; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03628963

  91. Primary completion Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes Registry record

    Expected 2019-11-30; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917784

  92. Study start Bivalirudin in Late PCI for Oatients With STEMI Registry record

    Expected 2019-11-30; that period ended on 2019-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04185077

  93. Study completion BioMime Vs. Xience Randomised Control Clinical Study Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02112981

  94. Study completion Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03421119

  95. Primary completion Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03421119

  96. Study completion Trial of Oral Melatonin in Elevated Blood Pressure Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764020

  97. Study start Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04129424

  98. Study start Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter Registry record

    Expected 2019-12-01; that period ended on 2019-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04141553

  99. Primary completion Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI Registry record

    Expected 2019-12-14; that period ended on 2019-12-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03381755

  100. Study completion Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting Registry record

    Expected 2019-12-15; that period ended on 2019-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03195673